Altered PTPRD DNA methylation associates with restricted adipogenesis in healthy first-degree relatives of Type 2 diabetes subjects

Epigenomics. 2020 May;12(10):873-888. doi: 10.2217/epi-2019-0267. Epub 2020 Jun 2.

Abstract

Aim: First-degree relatives (FDR) of individuals with Type 2 diabetes (T2D) feature restricted adipogenesis, which render them more vulnerable to T2D. Epigenetics may contribute to these abnormalities. Methods: FDR pre-adipocyte Methylome and Transcriptome were investigated by MeDIP- and RNA-Seq, respectively. Results:Methylome analysis revealed 2841 differentially methylated regions (DMR) in FDR. Most DMR localized into gene-body and were hypomethylated. The strongest hypomethylation signal was identified in an intronic-DMR at the PTPRD gene. PTPRD hypomethylation in FDR was confirmed by bisulphite sequencing and was responsible for its upregulation. Interestingly, Ptprd-overexpression in 3T3-L1 pre-adipocytes inhibited adipogenesis. Notably, the validated PTPRD-associated DMR was significantly hypomethylated in peripheral blood leukocytes from the same FDR individuals. Finally, PTPRD methylation pattern was also replicated in obese individuals. Conclusion: Our findings indicated a previously unrecognized role of PTPRD in restraining adipogenesis. This abnormality may contribute to increase FDR proclivity toward T2D.

Keywords: DNA methylation; Type 2 diabetes; adipose tissue; epigenetics; gene expression; pre-adipocyte.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3-L1 Cells
  • Adipogenesis / genetics*
  • Adult
  • Animals
  • DNA Methylation*
  • Diabetes Mellitus, Type 2 / genetics*
  • Epigenesis, Genetic
  • Female
  • Humans
  • Male
  • Mice
  • Receptor-Like Protein Tyrosine Phosphatases, Class 2 / genetics*

Substances

  • PTPRD protein, human
  • Receptor-Like Protein Tyrosine Phosphatases, Class 2